Osiris Therapeutics, Inc. (NASDAQ:OSIR)
CAPS Rating:
A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.
A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.
Recs
14 US$ 1 Nov 2009
14,1 US$ 20 Ener 2010